You have 9 free searches left this month | for more free features.

gsk961081

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pulmonary Disease, Chronic Obstructive Trial in London (GSK961081, GSK961081 matching )

Completed
  • Pulmonary Disease, Chronic Obstructive
  • GSK961081
  • GSK961081 matching placebo
  • London, United Kingdom
    GSK Investigational Site
Sep 28, 2021

Pulmonary Disease, Chronic Obstructive Trial in Harrow (GSK961081, GSK961081 matching , Propranolol)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • GSK961081
  • +3 more
  • Harrow, Middlesex, United Kingdom
    GSK Investigational Site
Sep 28, 2021

Pulmonary Disease, Chronic Obstructive Trial in Randwick (GSK961081, Fluticasone furoate)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • GSK961081
  • Fluticasone furoate
  • Randwick, New South Wales, Australia
    GSK Investigational Site
May 12, 2017

Pulmonary Disease, Chronic Obstructive Trial in Germany, South Africa (GSK961081)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • GSK961081
  • Mainz, Rheinland-Pfalz, Germany
  • +4 more
Feb 1, 2017

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GSK961081, Salmeterol, Placebo)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • GSK961081
  • +2 more
  • Tallinn, Estonia
  • +48 more
Nov 30, 2016